Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAR GraniteShares Gold Trust	$33.01 -0.1%	$33.04	$24.06 ▼ $34.04	$1.13B	0.15	765,530 shs	619,336 shs
CRL Charles River Laboratories International	$152.69 +2.5%	$156.11	$91.86 ▼ $230.02	$7.33B	1.48	974,273 shs	1.03 million shs
REVB Revelation Biosciences	$2.42 +1.7%	$2.57	$2.11 ▼ $168.00	$4.05M	-0.06	220,789 shs	24,695 shs
SKIN Beauty Health	$2.32 +5.0%	$1.80	$0.78 ▼ $2.38	$278.45M	1.2	1.30 million shs	1.70 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAR GraniteShares Gold Trust	-0.12%	-0.96%	-0.30%	+5.19%	+35.29%
CRL Charles River Laboratories International	+2.65%	-8.74%	-4.44%	+9.69%	-21.44%
REVB Revelation Biosciences	+1.68%	-6.56%	-13.26%	-74.23%	-94.54%
SKIN Beauty Health	+4.98%	+40.61%	+21.47%	+56.76%	+79.84%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAR GraniteShares Gold Trust	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRL Charles River Laboratories International	4.6434 of 5 stars	3.1	4.0	0.0	4.7	2.7	2.5	1.9
REVB Revelation Biosciences	0.2932 of 5 stars	0.0	2.0	0.0	0.0	0.8	0.0	1.3
SKIN Beauty Health	0.9928 of 5 stars	2.0	0.0	0.0	0.0	2.7	3.3	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAR GraniteShares Gold Trust	0.00	N/A	N/A	N/A
CRL Charles River Laboratories International	2.27	Hold	$175.69	15.07% Upside
REVB Revelation Biosciences	0.00	N/A	N/A	N/A
SKIN Beauty Health	2.00	Hold	$2.63	13.15% Upside

Current Analyst Ratings Breakdown

Latest BAR, SKIN, CRL, and REVB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	CRL Charles River Laboratories International	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$180.00 ➝ $190.00
8/7/2025	CRL Charles River Laboratories International	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$145.00 ➝ $160.00
8/7/2025	CRL Charles River Laboratories International	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$155.00 ➝ $165.00
8/1/2025	SKIN Beauty Health	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$3.00 ➝ $4.00
7/9/2025	CRL Charles River Laboratories International	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$170.00 ➝ $180.00
7/9/2025	CRL Charles River Laboratories International	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$150.00 ➝ $200.00
5/23/2025	CRL Charles River Laboratories International	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$188.00 ➝ $182.00
5/14/2025	CRL Charles River Laboratories International	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
5/14/2025	CRL Charles River Laboratories International	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$179.00

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAR GraniteShares Gold Trust	N/A	N/A	N/A	N/A	N/A	N/A
CRL Charles River Laboratories International	$4.05B	1.86	$22.26 per share	6.86	$68.26 per share	2.24
REVB Revelation Biosciences	N/A	N/A	N/A	N/A	$2.25 per share	N/A
SKIN Beauty Health	$334.30M	0.87	$0.07 per share	34.95	$0.59 per share	3.93

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAR GraniteShares Gold Trust	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
CRL Charles River Laboratories International	$22.20M	-$1.33	N/A	13.88	4.75	-1.69%	15.74%	7.09%	N/A
REVB Revelation Biosciences	-$15.04M	-$68.61	N/A	N/A	N/A	N/A	-240.27%	-148.95%	N/A
SKIN Beauty Health	-$29.10M	-$0.28	N/A	N/A	N/A	-6.13%	-32.82%	-2.96%	N/A

Latest BAR, SKIN, CRL, and REVB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	REVB Revelation Biosciences	-$4.46	-$7.01	-$2.55	-$7.01	N/A	N/A
8/7/2025	Q2 2025	SKIN Beauty Health	-$0.06	$0.03	+$0.09	$0.03	$74.67 million	$78.20 million
8/6/2025	Q2 2025	CRL Charles River Laboratories International	$2.50	$3.12	+$0.62	$1.06	$983.76 million	$1.03 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAR GraniteShares Gold Trust	N/A	0.00%	N/A	N/A	N/A
CRL Charles River Laboratories International	N/A	N/A	N/A	N/A	N/A
REVB Revelation Biosciences	N/A	N/A	N/A	N/A	N/A
SKIN Beauty Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAR GraniteShares Gold Trust	N/A	N/A	N/A
CRL Charles River Laboratories International	0.69	1.36	1.10
REVB Revelation Biosciences	N/A	3.60	3.60
SKIN Beauty Health	12.01	7.47	6.43

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAR GraniteShares Gold Trust	N/A
CRL Charles River Laboratories International	98.91%
REVB Revelation Biosciences	12.80%
SKIN Beauty Health	93.26%

Insider Ownership

Company	Insider Ownership
BAR GraniteShares Gold Trust	N/A
CRL Charles River Laboratories International	1.30%
REVB Revelation Biosciences	2.30%
SKIN Beauty Health	41.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAR GraniteShares Gold Trust	2,021	34.10 million	N/A	Not Optionable
CRL Charles River Laboratories International	20,100	49.21 million	48.57 million	Optionable
REVB Revelation Biosciences	10	1.70 million	1.50 million	Not Optionable
SKIN Beauty Health	1,030	125.99 million	74.34 million	Optionable

BAR, SKIN, CRL, and REVB Headlines

Recent News About These Companies

Beauty Health Co. Earnings Call Highlights Strong Performance

August 12 at 10:16 PM | tipranks.com

'My skin has never looked better' - beauty fans wowed by £10 Boots 'hydra' gel

August 12 at 7:05 PM | mirror.co.ukM

The 8 Best Sunscreens For Mature Skin, According To Dermatologists And Editors

August 12 at 7:05 PM | msn.com

Fast-paced Momentum Stock Beauty Health (SKIN) Is Still Trading at a Bargain

August 12 at 9:51 AM | zacks.com

Enhance your skin with Project E Beauty’s LumaLux LED Face Mask

August 11 at 11:17 PM | independent.co.ukI

International Markets and Beauty Health (SKIN): A Deep Dive for Investors

August 11 at 10:15 AM | zacks.com

What Expired Makeup Is Really Doing to Your Eyes and Skin

August 10 at 11:59 AM | msn.com

Beauty Health (NASDAQ:SKIN) Upgraded by Wall Street Zen to Buy Rating

August 10 at 3:32 AM | marketbeat.com

Use AI for skin care info, not treatment decisions: Expert

August 9, 2025 | dailysabah.comD

Confused about skincare? Start with this beginner’s guide for healthier skin

August 9, 2025 | cnalifestyle.channelnewsasia.comC

Beauty Health (NASDAQ:SKIN) Rating Increased to Buy at Wall Street Zen

August 9, 2025 | americanbankingnews.com

The Science Of Perfect Skin: Pour Moi’s Climate-Adaptive Skincare Redefines Beauty

August 9, 2025 | usmagazine.comU

BeautyHealth (NASDAQ:SKIN) Delivers Impressive Q2, Stock Jumps 18.7%

August 9, 2025 | msn.com

Beauty Health raises 2025 sales and EBITDA guidance amid margin gains and innovation push

August 9, 2025 | msn.com

The Beauty Health Company (SKIN) Q2 2025 Earnings Call Transcript

August 8, 2025 | seekingalpha.com

Beauty Health (SKIN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

August 7, 2025 | zacks.com

The Beauty Health Company (SKIN) Surpasses Q2 Earnings and Revenue Estimates

August 7, 2025 | zacks.com

Beauty Health (SKIN) Q2 Net Jumps 62%

August 7, 2025 | fool.com

Why your skincare routine might be good for your mental health too

August 7, 2025 | msn.com

13 French skincare and beauty brands you can shop without a trip to Paris

August 7, 2025 | msn.com

Baobab fruit powder: Your secret to glowing skin

August 7, 2025 | newsbytesapp.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BAR, SKIN, CRL, and REVB Company Descriptions

GraniteShares Gold Trust NYSEARCA:BAR

$33.01 -0.04 (-0.12%)

Closing price 08/12/2025 04:10 PM Eastern

Extended Trading

$33.00 -0.01 (-0.03%)

As of 04:28 AM Eastern

The GraniteShares Gold Trust (BAR) is an exchange-traded fund that is based on the LBMA Gold Price index. The fund tracks the gold spot price, less trust expenses and liabilities, using physically held gold stored and secured in vaults in London. BAR was launched on Aug 31, 2017 and is managed by GraniteShares.

Charles River Laboratories International NYSE:CRL

$152.69 +3.76 (+2.52%)

Closing price 08/12/2025 03:59 PM Eastern

Extended Trading

$152.74 +0.05 (+0.03%)

As of 08/12/2025 06:08 PM Eastern

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Revelation Biosciences NASDAQ:REVB

$2.42 +0.04 (+1.68%)

Closing price 08/12/2025 04:00 PM Eastern

Extended Trading

$2.42 0.00 (-0.21%)

As of 08/12/2025 07:57 PM Eastern

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

Beauty Health NASDAQ:SKIN

$2.32 +0.11 (+4.98%)

Closing price 08/12/2025 04:00 PM Eastern

Extended Trading

$2.25 -0.07 (-3.02%)

As of 04:09 AM Eastern

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time